PPARA and hyperlipidemia: Therefore, the role of PPARα in the development of renal diseases has recently been extensively studied (Wang, 2010), such as in mouse kidney tissues with hyperlipidemia (Chung et al., 2018)and renal stone disease (Su et al., 2020).